H2 Receptor Antagonists - Acid's Off Switch
- Location: Gastric parietal cells, targeting H2 receptors.
- Mechanism: Competitive antagonists of histamine; prevent histamine binding.
- Pathway: Block histamine-induced Gs protein activation $\rightarrow$ adenylyl cyclase inhibition $\rightarrow$ ↓ cAMP levels $\rightarrow$ ↓ protein kinase A activity $\rightarrow$ reduced proton pump (H+/K+ ATPase) activation.
- Effect: Significantly reduce gastric acid secretion, both basal (especially nocturnal) and stimulated (e.g., by food, gastrin).
- Efficacy: Decrease total 24-hour acid output by approximately 70%.
⭐ H2 blockers are particularly effective at suppressing basal (nocturnal) acid secretion, making them useful for nocturnal heartburn.

H2 Receptor Antagonists - Tidine Titans
- All end in "-tidine". Competitively block H2 receptors on parietal cells, ↓ acid secretion.
| Feature | Cimetidine | Ranitidine | Famotidine | Nizatidine |
|---|---|---|---|---|
| Rel. Potency | 1x | 4-10x | 20-50x | 4-10x |
| Duration (hrs) | 4-6 | 6-8 | 10-12 | 6-8 |
| Bioavailability | ~70% | ~50% | ~40-45% | >90% (highest) |
| Metabolism | Hepatic (CYP450 inhibitor) | Hepatic (minimal CYP interaction) | Hepatic (minimal CYP interaction) | Renal excretion (minimal metab) |
| Side Effects | Antiandrogenic (gynecomastia, impotence), confusion (elderly), inhibits CYP450 📌 CIMETIDINE = Cytochrome Inhibitor Man | Few, well-tolerated | Few, well-tolerated | Few, well-tolerated |
H2 Receptor Antagonists - Gut Guardians

Key Indications:
- Peptic Ulcer Disease (PUD)
- Gastric ulcers
- Duodenal ulcers (Healing rates: 70-80% at 4 weeks, 85-95% at 8 weeks with cimetidine)
- Gastroesophageal Reflux Disease (GERD)
- Zollinger-Ellison syndrome (adjunct therapy)
- Non-ulcer dyspepsia
- Prevention of stress ulcers (especially in critically ill patients)
⭐ H2 blockers are generally less effective than Proton Pump Inhibitors (PPIs) for healing severe erosive esophagitis or NSAID-induced ulcers, and for rapid symptom relief in GERD.
📌 Mnemonic: "DINE with H2 Blockers" (Cimetidine, Ranitidine, Famotidine, Nizatidine - though some may be less common now).
H2 Receptor Antagonists - Side Effect Signals
- General Side Effects:
- Headache, dizziness
- Diarrhea, constipation
- Confusion (especially in elderly or renal impairment)
- Cimetidine Specifics (📌 Cimetidine can cause 'Man-boobs, Muddled mind, and Messed-up metabolism'):
- Antiandrogenic: Gynecomastia, galactorrhea, impotence
- Enzyme Inhibition: Potent CYP450 inhibitor (especially CYP1A2, 2C9, 2D6, 3A4)
- Drug Interactions (Cimetidine):
- ↑ levels of warfarin, phenytoin, theophylline, benzodiazepines, propranolol
- Rare Side Effects:
- Rapid IV infusion: Bradycardia, hypotension, arrhythmias (rare)
- Blood dyscrasias (e.g., thrombocytopenia)
- Tolerance:
- Pharmacodynamic tolerance can develop to acid suppression.
⭐ Tolerance to the acid-suppressing effects of H2 blockers can develop within 3 days of starting therapy, leading to ↓ efficacy with continued use.
High‑Yield Points - ⚡ Biggest Takeaways
- H2 blockers (e.g., Cimetidine, Ranitidine, Famotidine) reversibly inhibit H2 receptors on parietal cells, ↓ acid secretion.
- Cimetidine: Notable CYP450 inhibitor (drug interactions) and antiandrogenic effects (gynecomastia, impotence).
- Famotidine: Most potent; Nizatidine: High bioavailability.
- Clinical uses: Peptic ulcer disease (PUD), GERD, Zollinger-Ellison syndrome.
- Adverse effects: Generally well-tolerated; CNS effects (confusion, dizziness) in elderly or with renal impairment.
- Tolerance can develop with prolonged use.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app